Ausdal Financial Partners’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.99K Hold
12,476
﹤0.01% 690
2025
Q1
$2.46K Buy
+12,476
New +$2.46K ﹤0.01% 644